查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362891

臨床試驗配對軟體市場規模、佔有率、趨勢分析報告：按部署模式、最終用途、地區和細分市場預測，2023-2030 年

Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud-based, On-premise), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗匹配軟體市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球臨床試驗配對軟體市場規模預計將達到 3.961 億美元。

預計2023年至2030年年複合成長率為13.2%。正在進行的臨床試驗數量的大幅增加預計將推動市場發展。此外，擴大採用臨床試驗配對軟體進行臨床試驗，以及醫療保健領域對虛擬測試和自動化的需求不斷增加，也是促進市場成長的關鍵要素之一。配對軟體有助於透過以患者為中心的方法進行有效、快速的患者配對。

在臨床試驗中，招募和配對患者可能非常耗時，而且找到合適的配對對像也很困難。篩選和搜尋合格的潛在受訪者、考慮臨床實驗的各個方面、建立意識並獲得參與的知情同意是患者招募過程中考慮的因素。根據資格要求招募人員至關重要，因此試驗配對技術已被證明是有用的，特別是在 COVID-19 情況下。

該軟體不僅可以幫助找到合適的匹配，還可以節省研發相關成本，並在無需人工干涉的情況下實現平穩操作。軟體供應商正在引入新的創新技術來鞏固其市場地位。例如，2022 年 2 月，CTMA 擴大了 CT-SCOUT 技術在風濕病領域的應用。

臨床試驗配對軟體市場的報告亮點：

  • 根據部署模式，基於網路和雲端基礎市場預計將在 2022 年以收益主導市場，並在預測期內實現最快的年複合成長率。雲端運算模式不需要維護或保養，客戶只需為他們使用的服務付費。另一方面，本地部署需要內部基礎架構、內部 IT 支援、營運資金和高整合成本。因此，雲端基礎的模型是首選。
  • 按最終用途分類，製藥和生物技術公司在 2022 年獲得了最大的收益佔有率，因為在正在進行的臨床研究中擴大採用軟體來降低研發活動的成本。
  • CRO 最終用途領域預計在預測期內將以 13.7% 的年複合成長率成長最快。 CRO 可以快速提供臨床試驗所需的專業支援、專業知識和實施經驗，而無需申辦者聘請全職人員。 CRO 服務是首選的外包目的地，因為它們具有成本效益和時間效益。
  • 2022 年，隨著製藥、生物技術和醫療保健相關企業擴大採用臨床試驗匹配軟體，北美在企業收益方面領先市場。
  • 由於有大量患者群支援輕鬆招募患者/候選人，預計亞太地區將在預測期內實現最快的成長率。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 臨床試驗配對軟體市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 臨床試驗配對軟體市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 臨床試驗匹配軟體：部署模式估算與估算/趨勢分析

  • 臨床試驗配對軟體市場：重點
  • 臨床試驗匹配軟體市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 雲端基礎
    • 2018 年至 2030 年網路和雲端基礎的市場估計和預測
  • 本地
    • 2018 年至 2030 年本地市場估計與預測

第5章 臨床試驗配對軟體：最終用途估算與趨勢分析

  • 臨床試驗配對軟體市場：重點
  • 臨床試驗匹配軟體市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 製藥和生物技術公司
  • CRO
  • 醫療設備公司

第6章 臨床試驗配對軟體市場：區域估計與趨勢分析

  • 區域預測
  • 按地區分類的臨床試驗匹配軟體市場：市場要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • IBM Clinical Development
    • Antidote Technologies, INC.
    • Ofni Systems
    • Sss International Clinical Research
    • Clario
    • Advarra
    • Aris Global
    • Bsi Business Systems Integration Ag
    • Teckro
    • Clinical Trials Mobile Application
Product Code: GVR-4-68039-921-8

Clinical Trials Matching Software Market Growth & Trends:

The global clinical trials matching software market size is expected to reach USD 396.1 million by 2030, based on a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 13.2% from 2023 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches.

In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 scenario.

The software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in rheumatology.

Clinical Trials Matching Software Market Report Highlights:

  • Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2022 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred
  • Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2022 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities
  • The CROs end-use segment is anticipated to expand at the fastest CAGR of 13.7% during the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective
  • In 2022, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Deployment Mode
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Deployment mode outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Matching Software Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Trials Matching Software Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Clinical Trials Matching Software: Deployment Mode Estimates & Trend Analysis

  • 4.1. Clinical Trials Matching Software Market: Key Takeaways
  • 4.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Web & Cloud-based
    • 4.3.1. Web & Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. On-premises
    • 4.4.1. On-premises market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Matching Software: End-use Estimates & Trend Analysis

  • 5.1. Clinical Trials Matching Software Market: Key Takeaways
  • 5.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. CROs
    • 5.4.1. CROs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Medical Device Firms
    • 5.5.1. Medical Device Firms market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Matching Software Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Trials Matching Software Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. IBM Clinical Development
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Antidote Technologies, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Ofni Systems
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Sss International Clinical Research
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Clario
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Advarra
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Aris Global
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Bsi Business Systems Integration Ag
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Teckro
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Clinical Trials Mobile Application
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 15 UK clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 17 France clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 23 Sweden clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 25 Norway clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 27 Denmark clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 31 China clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 32 China clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 34 Japan clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 36 India clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 37 Australia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 39 Thailand clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical trials matching software: Market outlook
  • Fig. 9 Clinical trials matching software: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical trials matching software market driver impact
  • Fig. 15 Clinical trials matching software market restraint impact
  • Fig. 16 Clinical trials matching software market strategic initiatives analysis
  • Fig. 17 Clinical trials matching software market: Deployment mode movement analysis
  • Fig. 18 Clinical trials matching software market: Deployment mode outlook and key takeaways
  • Fig. 19 Web & cloud-based market estimates and forecasts, 2018 - 2030
  • Fig. 20 On-premises market estimates and forecasts, 2018 - 2030
  • Fig. 21 Clinical trials matching software market: End-use movement analysis
  • Fig. 22 Clinical trials matching software market: End-use outlook and key takeaways
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 24 CROs market estimates and forecasts, 2018 - 2030
  • Fig. 25 Medical devices firms market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global clinical trials matching software market: Regional movement analysis
  • Fig. 27 Global clinical trials matching software market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030